PD-L1 and PD-L2, which are known to be expressed on the surfaces of APC and cancer cells, engage PD-1, which is expressed on CD8-positive cytotoxic T lymphocytes (CTLs), as negative immune regulators [4, 5]. This evidence concerns the gene PDCD1LG2 and cancer.